Open access
Open access
Powered by Google Translator Translator

#AHA20 – Randomized trial: In elective percutaneous coronary intervention Clopidogrel led to similar outcomes compared with Ticagrelor with less minor bleeding

16 Nov, 2020 | 01:55h | UTC

Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial – The Lancet

News release: Ticagrelor was not superior to clopidogrel to reduce heart attack risk during angioplasty – American Heart Association

Commentaries: Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS – TCTMD AND Ticagrelor Not Superior to Clopidogrel for Elective PCI – NEJM Journal Watch

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.